Physician profile

Gregory Douds

Neurological Surgery · Las Vegas, NV

NPI 1407072382

$29,297.39

in general payments reported to CMS, 2019-2025

43 companies · $2,288 in 2025

The $2,288 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$10,436.39
Travel and Lodging$1,665.77

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $8,974.28 2019-2024 Everest Spinal System, Monterey Al, Yukon Oct Spinal System
Nuvasive, INC. $4,596.76 2019-2023
Providence Medical Technology, INC. $3,597.63 2021-2025
Choice Spine, LLC $2,326.57 2019-2020
Medtronic, INC. $2,124.54 2021-2025 Mazor X System, Inceptiv, Intellis Adaptivestim
Abbott Laboratories $1,966.57 2021-2025 Penta, Proclaim, Eterna
Boston Scientific Corporation $831.84 2019-2025 General - Pain Management, Intracept, Artisan
Medtronic USA, INC. $706.34 2019-2020
Nevro Corp. $702.93 2020-2024 Senza
Spinal Elements, INC. $674.11 2024-2025
Biotronik Nro, INC. $334.46 2024-2025 Prospera
Seaspine Orthopedics Corporation $226.73 2022
Intrinsic Therapeutics $193.57 2025 Barricaid Acd (Annular Closure Device)
Alphatec Spine, INC $191.14 2022-2023
Saluda Medical Americas, INC. $175.08 2024 Evoke
Show all 43 companies
CompanyGeneral paymentsYearsTop products
Flowonix Medical Incorporated $165.89 2019
Penumbra, INC. $159.55 2020
Balt USA, LLC $147.37 2021-2022
Monteris Medical Corporation $99.29 2019
Depuy Synthes Sales INC. $96.58 2020-2021
Portola Pharmaceuticals, LLC $95.09 2019-2020
Spineology INC. $85.38 2021-2025
Globus Medical, INC. $77.79 2021-2025 Omnia
Kls-Martin L.P. $76.03 2019-2025
Pacira Pharmaceuticals Incorporated $63.78 2019-2023 Exparel
Sanara Medtech INC. $62.17 2024-2025 Celleraterx, Biform
Innovation Technologies INC $56.20 2022
Aesculap, INC. $49.10 2024 Aesculap
Arbor Pharmaceuticals, INC. $47.73 2019-2021
Si-Bone, INC. $46.58 2022-2024
Smith+Nephew, INC. $43.93 2025 Pico
Omniscient Neurotechnology America Ltd $42.00 2022
Vertex Pharmaceuticals Incorporated $37.78 2025
Ethicon US, LLC $36.66 2021-2023 Mega Soft
Biocomposites INC $33.40 2025 Stimulan
Astrazeneca Pharmaceuticals Lp $30.92 2022
Dilon Technologies, INC. $26.82 2025 Hemoblast Bellows
Integra Lifesciences Corporation $23.02 2019
Ceribell, INC. $16.26 2022
Azurity Pharmaceuticals, INC. $15.32 2023 Gliadel
Stimwave Technologies Incorporated $13.99 2021
Livanova USA, INC. $13.12 2023 Vns Therapy Sentiva Model 1000 Generator
Zimmer Biomet Holdings, INC. $13.09 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Gregory Douds

$29,297.39

in general payments reported 2019-2025

Years
2019-2025
Top company
Stryker Corporation
Context
The $2,288 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).

https://glasscript.com/doctor/108470/gregory-douds

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.